anticancer peptide prediction ACP-ESM2 offers a highly accurate tool - MLACP 2.0 ACP-CapsPred Advancing Cancer Therapy: The Crucial Role of Anticancer Peptide Prediction

ACPred The quest for more effective and targeted cancer therapies has led to a significant focus on anticancer peptides (ACPs). These naturally occurring or synthetically designed molecules exhibit selective cytotoxicity, meaning they can target and destroy cancer cells while sparing healthy ones.作者：HW Park·2022·被引用次数：75—Predicting anticancer peptides from sequence informationis one of the most challenging tasks in immunoinformatics. This selectivity, coupled with their ability to modulate immune responses, positions ACPs as promising therapeutic agents. However, identifying and developing these peptides is a complex and time-consuming process. This is where the field of anticancer peptide prediction emerges as a critical area of research, leveraging computational tools and machine learning to accelerate discovery.

The challenge lies in accurately predicting whether a given peptide sequence possesses anticancer activity.EnsemPred-ACP: Combining machine and deep learning ... This task, often referred to as predicting anticancer peptides from sequence information, is a cornerstone of modern immunoinformatics and drug discoveryACP-CLB: An Anticancer Peptide Prediction Model Based on .... Recent advancements have seen the development of numerous sophisticated computational models and databases dedicated to this purpose. For instance, MLACP 2.0 and its predecessor have been instrumental in predicting ACPs solely from sequence data. Similarly, PLMACPred is another machine learning-based predictor that focuses on identifying ACPs using peptide sequences.

The sophistication of these prediction tools continues to evolve. Researchers are exploring various machine learning and deep learning approaches to enhance accuracy and interpretability. Frameworks like ACP-CLB employ multichannel discriminative processing with different neural networks to analyze various featuresACP-DA: Improving the Prediction of Anticancer Peptides .... mACPpred 2ACPScanner: Prediction of Anticancer Peptides by Integrated ....0 integrates spatial and probabilistic feature representations, while ACPPfel utilizes an explainable deep ensemble learning approach作者：M Arif·2024·被引用次数：20—A machine learning-based predictor, calledPLMACPred, is developed for identifying ACPs from peptide sequence only.. The development of MA-PEP highlights the use of multiple attention mechanisms for feature enhancement and fusion, leading to improved ACP prediction.

Furthermore, the integration of advanced deep learning architectures has proven highly effective. ACP-ESM2, for example, combines the power of ESM2 with convolutional neural networks (CNNs) to detect local patterns, offering a highly accurate tool for ACP identification. ACPred-BMF is a deep learning-based predictor designed for ACP prediction, and ACP-CapsPred offers a two-stage computational framework for accurate ACP identification and functional characterization. The topology-enhanced machine learning model (Top-ML) represents another innovative approach to ACP prediction.

Several studies have focused on creating comprehensive repositories and specialized tools. CancerPPD2 is an updated repository of anticancer peptides, detailing their sequences, lengths, experimental techniques, and structuresACP-DA: Improving the Prediction of Anticancer Peptides .... ACPred, a well-cited bioinformatics tool, not only predicts but also characterizes ACPs. AntiCP serves as a web-based prediction server for anticancer peptides, utilizing Support Vector Machine (SVM) models based on amino acid composition and binary profile features. ACPScanner offers an integrated approach to predict ACPs and non-ACPs, and subsequently, specific activity types.

The drive for enhanced accuracy in anticancer peptide prediction also involves exploring diverse feature extraction techniques. ACP-ML, for instance, leverages features such as Dictionary-based Protein Composition (DPC), Pseudo Amino Acid Composition (PseAAC), Tri-peptide Composition (CTDC), Tri-peptide Coupling (CTDT), and Correlation Spectra Pse-PSSM (CS-Pse-PSSM). Other methods, like AttBiLSTM_DE, accurately predict ACPs by integrating multi-scale feature representations, including One-hot encoding and fastText. The effectiveness of these methods in accurately predicting anticancer peptides and capturing intricate spatial patterns is continuously being validated.

The increasing availability of data also fuels the development of more robust modelsAntiCP: Prediction and Designing of Anticancer Peptides. ACP-DA employs data augmentation techniques to improve prediction accuracy when dealing with insufficient samples. These advancements in prediction are crucial for accelerating the development of new anticancer drugs. Exploring the anticancer activity of peptides by using ACP predictors can significantly speed up the discovery pipeline. This is essential for translating promising research into tangible therapeutic solutions.作者：MJN Juthy·2025—This modelaccurately predicts anticancer peptidesby integrating multi-scale feature representations, including One-hot encoding, fastText, and ...

In essence, the field of anticancer peptide prediction is a dynamic and rapidly evolving area within computational biology. By harnessing sophisticated machine learning algorithms, deep learning architectures, and curated databases, researchers are making significant strides in identifying and developing novel ACPs. Tools like ACPred, MLACP 2.Topology-Enhanced Machine Learning Model (Top-ML) for ...0, and ACP-ESM2 offers a highly accurate tool are empowering scientists to accurately predict the likelihood of a peptide exhibiting anticancer activity, ultimately paving the way for more effective and targeted cancer therapies. The continuous development of new ACP prediction models and the exploration of novel features are vital steps in the ongoing fight against cancerACP-ESM2: Anticancer Peptide Prediction Using Protein ....